NorayBio, a bioinformatics company located at the Bizkaia Technological Park (Basque Country) and specialising in developing software for the biosciences, has launched a new software for cancer research on to the market - BITIA, primarily aimed at research centres and cancer wards in hospitals.
BITIA aims to help oncologists to answer the question that has been around for some time: Why is it that two patients with very similar pathology profiles respond in distinct ways to treatment? It is in the genes that the answer has been looked for and recent studies have revealed that the differentiated expression of some genes is involved in the risk of developing metastasis in some kinds of cancer. The BITIA software establishes relations between genic data and clinical data of cancer patients, providing new prognostic factors. In this way, BITIA aims to be a support tool for oncologists when taking decisions.
BITIA has been designed and developed by NorayBio in collaboration with the Professor of Oncology and Palliative Medicine at the Autonomous University of Madrid and the Cancer Medical Service at the La Paz University Hospital, directed by Professor Dr. Manuel Gonzalez Barón. The involvement in this project of a multidisciplinary team of cancer specialists, molecular biologists, software engineers and statisticians has enabled the development of an easy-to-use and powerful tool for the scientific and medical community.
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences